NCT05883904View on ClinicalTrials.gov

Real World Evidence of Fedratinib Effectiveness in MF

RecruitingOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Interventions
DRUG

Fedratinib

Fedratinib administered after AIFA reimbusement approval

Trial Locations (1)

Unknown

RECRUITING

Ematologia FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO, Milan

All Listed Sponsors
lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER